BPC-157: The Regenerative Standard in Peptide Research
Analyzing the angiogenic and reparative mechanisms of Pentadecapeptide BPC-157 in tendon and gut health models.
Background
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a larger protein fragment originally isolated from human gastric juice. Since its initial characterization in the 1990s by Sikirić and colleagues, it has become one of the most extensively studied peptides in regenerative research, with hundreds of preclinical publications spanning gastrointestinal, musculoskeletal, cardiovascular, and neurological models.
Molecular profile
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 aa)
- Molecular weight: ~1,419 Da
- Source: partial sequence of human gastric BPC (body protection compound)
- Notable property: exceptional stability in gastric juice — resists pepsin cleavage, which is atypical for peptides and enables both parenteral and oral research administration
Mechanism: angiogenesis and tissue repair
The core reparative activity of BPC-157 in research models centers on angiogenesis — formation of new blood vessels from existing vasculature — and modulation of several growth-factor signaling pathways:
- VEGF upregulation — vascular endothelial growth factor drives endothelial cell proliferation, migration, and capillary formation
- VEGFR2 (KDR) signaling — BPC-157 promotes VEGFR2 internalization and activation of the Akt-eNOS pathway
- Nitric oxide (NO) axis — increased NO bioavailability contributes to vasodilation and microvascular repair
- Growth hormone receptor sensitization — upregulation of GHR expression in fibroblasts and tendon cells
- FAK and paxillin activation — enhances fibroblast migration to sites of injury
- Tendon-specific outgrowth — upregulation of tenascin-C and improved tenocyte function in explant models
What laboratories typically study
Gastrointestinal models:
- NSAID-induced ulcer models (indomethacin, aspirin)
- Inflammatory bowel disease (DSS colitis, TNBS colitis)
- Gastric and esophageal fistula healing
- Intestinal anastomosis studies
Musculoskeletal models:
- Transected Achilles tendon repair in rats
- Medial collateral ligament transection studies
- Muscle crush injury recovery
- Corticosteroid-impaired tendon healing reversal
Cardiovascular and neural models:
- Ischemia-reperfusion injury (heart, brain)
- Gut-brain axis research — potential neuroprotective effects
- Traumatic brain injury models
- Neuropathic pain studies
Administration and stability in research
- Supplied as lyophilized powder; typical research format 5 mg
- Store lyophilized at -20°C, protected from light
- Reconstitute with sterile/bacteriostatic water immediately before use
- Reconstituted solution stable ~4 weeks at 2–8°C
- Oral administration studied in rodent models due to gastric stability; subcutaneous and intraperitoneal routes are more common in controlled studies
- Verify purity by HPLC (≥99.0%) with mass-spectrometric identity confirmation; request batch COA
Related compounds for comparison
- TB-500 (Thymosin β4) — complementary repair mechanism via actin dynamics; often paired in research (see /blog/tb-500-actin-regulation-cellular-mobility)
- GHK-Cu — copper tripeptide with distinct wound-healing mechanism
- IGF-1 LR3 — downstream anabolic signaling for combined repair studies
Related reading
- /research/bpc-157 isn't currently a dedicated profile — see /category/healing-and-regeneration-research
- /compare/bpc-157-vs-ghk-cu — mechanism comparison
- /compare/kpv-vs-bpc-157 — GI-focused peptide comparison
- /blog/tb-500-actin-regulation-cellular-mobility — common research pairing
- /guides/how-to-store-peptides — lyophilized handling
RUO disclaimer
For laboratory research use only. Not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption outside approved research settings. Most human data is from non-regulated contexts; published research is almost exclusively preclinical.